These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7198291)

  • 61. [Chemotherapy of bronchopulmonary and pleural adenocarcinoma. Apropos of 31 cases].
    Lebeau B; Brechot JM; Ameille J; de Fenoyl O; Rochemaure J
    Rev Pneumol Clin; 1985; 41(2):135-7. PubMed ID: 3839592
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
    Lv C; An C; Feng Q; Ma Y; Li S; Wang J; Zhang J; Wang X; Yan S; Fang J; Wang Y; Tan F; Yang Y
    Clin Lung Cancer; 2015 Nov; 16(6):e173-81. PubMed ID: 25958850
    [TBL] [Abstract][Full Text] [Related]  

  • 63. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 64. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
    Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical analysis of the current treatment status of gastric cancer in 636 patients].
    Zhuang QX; Xu JM; Lin L; Ge FJ; Liu LJ; Wang Y; Zhao CH
    Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):316-20. PubMed ID: 22781048
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cis-platinum-adriamycin-cyclophosphamide in the treatment of advanced-recurrent cervical cancer.
    Villalon AH; Lu-Lim JY; Esteba DV; Manalo A; Sotto L; Jimenez MV; Agustin BM
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):660-4. PubMed ID: 3841763
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Alternative combination chemotherapy with mitomycin C, vincristine, methotrexate, 5-fluorouracil, cis-platinum and adriamycin for adenocarcinoma of the lung].
    Xing FY; Liu WH; Dong W; Zhang SL; Gu BW; Okazaki K; Naito H; Inoue T; Wu JT; Tamura S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):259-63. PubMed ID: 8434964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metastatic carcinoma of uncertain primary site: a retrospective review of 57 patients treated with vincristine, doxorubicin, cyclophosphamide (VAC) or VAC alternating with cisplatin and etoposide (VAC/PE).
    de Campos ES; Menasce LP; Radford J; Harris M; Thatcher N
    Cancer; 1994 Jan; 73(2):470-5. PubMed ID: 8293415
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
    Logothetis CJ; Samuels ML; Selig DE; Ogden S; Dexeus F; Swanson D; Johnson D; von Eschenbach A
    Am J Med; 1986 Aug; 81(2):219-28. PubMed ID: 2426944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer of unknown primary site.
    Ultmann JE
    J Cancer Res Clin Oncol; 1991; 117(6):505-9. PubMed ID: 1744156
    [No Abstract]   [Full Text] [Related]  

  • 74. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
    Parker LM; Griffiths CT; Yankee RA; Canellos GP; Gelman R; Knapp RC; Richman CM; Tobias JS; Weiner RS; Frei E
    Cancer; 1980 Aug; 46(4):669-74. PubMed ID: 7397632
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
    Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adenocarcinoma of unknown primary origin: impact of chemotherapy on survival.
    Indupalli SR; Bedikian AY; Bodey GP
    South Med J; 1981 Dec; 74(12):1431-5. PubMed ID: 7198291
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.